AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Find out Which Dividend Growth ETF Has Low Fees and what to look for in expense ratios. Get tips to compare funds effectively.
28,299 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Rambus is gaining traction as AI workloads push memory bandwidth needs higher, fueling renewed investor interest and ...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
Analysts are signaling a higher cost-of-living adjustment for 2027 as inflation persists, with estimates pointing to ...
Oil prices surged after Iran closed the Strait of Hormuz again, renewing inflation concerns and pressuring Fed policy...
OpenAI secures a historic $110 billion funding round from Amazon, Nvidia and SoftBank, driving its valuation to about...
Lucid jumps 9%, NIO climbs 7%, and Tesla rises about 4% as the broader EV complex gets a fresh bid amid demand signal...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
The world’s hottest stock market dropped about 7% over two trading days as international investors pulled funds, sign...
A market thinker known as the prophet ‘wired belt’ warns that AI-driven shifts are hollowing out knowledge-economy jo...
A new tech-specific volatility metric is approaching its highest level in two decades, underscoring rising nerves aro...
Optics names retreat after a one-day surge driven by sector optimism. Credo Drops 15%, Lumentum slides 11%, AAOI decl...